Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia

Journal of Immunology

Volumn 171, Issue 11, 2003, Pages 6072-6079

  Kim, Hee Young ^a   Park, Eun Jung ^a   Joe, Eun Hye ^a   Jou, Ilo ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2; GAMMA INTERFERON; GANGLIOSIDE; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 2; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION; GENETIC ASSOCIATION; INFLAMMATION; INHIBITION KINETICS; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SRC HOMOLOGY DOMAIN; STIMULATION;

EID: 0345016388     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.11.6072     Document Type: Article

References (54)

1. Streit, W. J., S. A. Walter, and N. A. Pennell. 1999. Reactive microgliosis. Prog. Neurobiol. 57:563.
2. Fischer, H., and G. Reichmann. 2001. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166:2717.
3. Chao, C. C., W. R. Anderson, S. Hu, G. Gekker, A. Martella, and P. K. Peterson. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:178.
4. Wink, D. A., I. Hanbauer, M. C. Krishna, W. DeGraff, J. Gamson, and J. B. Mitchell. 1993. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA 90:9813.
5. Banati, R. B., G. Rothe, G. Valet, and G. W. Kreutzberg. 1991. Respiratory burst activity in brain macrophages: a flow cytometric study on cultured rat microglia. Neuropathol. Appl. Neurobiol. 17:223.
6. Chao, C. C., S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736.
7. Giulian, D., L. J. Haverkamp, J. H. Yu, W. Karshin, D. Tom, J. Li, J. Kirkpatrick, L. Kuo, and A. E. Roher. 1996. Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:6021.
8. Giulian, D., and T. J. Baker. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6:2163.
9. Giulian, D., L. J. Haverkamp, J. Li, W. L. Karshin, J. Yu, D. Tom, X. Li, and J. B. Kirkpatrick. 1995. Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27:119.
10. McGeer, P. L., S. Itagaki, S. Tago, and E. G. McGeer. 1987. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurosci. Lett. 79:1285.
11. Kreutzberg, G. W. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:312.
12. Dell'Albani, P., R. Santangelo, L. Torrisi, V. G. Nicoletti, J. Vellis, and A. M. Giuffrida Stella. 2001. JAK/STAT Signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 65:417.
13. Rane, S. G., and E. P. Reddy. 2000. Janus kinases: components of multiple signaling pathways. Oncogene 19:5662.
14. Hackett, R. H., Y.-D. Wang, S. Sweitzer, G. Feldman, W. I. Wood, and A. C. Larner. 1997. Mapping of a cytoplasmic domain of the human growth hormone receptor that regulates rates of inactivation of Jak2 and Stat proteins. J. Biol. Chem. 272:11128.
15. Schindler, C. 1999. Cytokine and JAK-STAT signaling. Exp. Cell Res. 253:7.
16. Cull, V. S., P. A. Tilbrook, E. J. Bartlett, N. L. Brekalo, and C. M. James. 2003. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood 101:2727.
17. 727 phosphorylation, differentially affecting specific target gene expression. EMBO J. 20:91.
18. Park, C., and C. Schindler. 1998. Protein-DNA interactions in interferon-γ signaling. Methods 15:175.
19. Wen, Z., A. Zhong, and J. E. Darnell. 1995. Maximal activation of transcription by Star1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241.
20. Starr, R., and D. Hilton. 1999. Negative regulation of the JAK/STAT pathway. Bioassays 21:47.
21. Naka, T., M. Narazaki, M. Hirata, T. Matsumoto, S. Minamoto, A. Aono, N. Nishimoto, T. Kajita, T. Taga, K. Yoshizaki, et al. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924.
22. Starr, R., T. A. Willson, E. M. Viney, L. J. Murray, J. R. Rayner, B. J. Jenkins, T. J. Gonda, W. S. Alexander, D. Metcalf, N. A. Nicola, and D. J. Hilton. 1997. A family of cytokine-inducible inhibitors of signaling. Nature 387:917.
23. Endo, T. A., M. Masuhara, M. Yokouchi, R. Suzuki, H. Sakamoto, K. Mitsui, A. Matsumoto, S. Tanimura, M. Ohtsubo, H. Misawa, et al. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921.
24. Krebs, D. L., and D. J. Hilton. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378.
25. Jiao, H., K. Berrada, W. Yang, M. Tabrizi, L. C. Platanias, and T. Yi. 1996. Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containg protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16:6985.
26. Kui, C. 2000. The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res. 10:279.
27. You, M., D.-H. Yu, and G.-S. Feng. 1999. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated JAK/STAT pathway. Mol. Cell Biol. 19:2416.
28. 759-dependent attenuation of interleukin-6 signaling through gp130. J. Biol. Chem. 278:661.
29. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441.
30. Lu, W., D. Gong, D. Bar-Sagi, and P. A. Cole. 2001. Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell 8:759.
31. Huang, M. T., T. Lysz, T. Ferrero, T. F. Abidi, J. D. Laskin, and A. H. Conney. 1991. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:813.
32. Rao, C. V., A. Rivenson, B. Simi, and B. S. Reddy. 1995. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:259.
33. Oetari, S., M. Sudibyo, J. N. M. Commandeur, R. Samhoedi, and N. P. E. Vermeulen. 1996. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem. Pharmacol. 51:39.
34. Huang, T.-S., S. C. Lee, and J. K. Lin. 1991. Suppression of c-jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblase cells. Proc. Natl. Acad. Sci. USA 88:5292.
35. Jobin, C., C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor. 1999. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J. Immunol. 163:3474.
36. Singh, S., and B. B. Aggarwal. 1995. Activation of transcription factor NF-κB is suppressed by curcumin. J. Biol. Chem. 270:24995.
37. Kim, O. S., E. J. Park, E. H. Joe, and I. Jou. 2002. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J. Biol. Chem. 277:40594.
38. Park, E. J., S. Y. Park, E. Joe, and I. Jou. 2003. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS 1) and SOCS3 in glia. J. Biol. Chem. 278:14747.
39. Plummer, S. M., K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farow, and L. Howells. 1999. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-Bκ activation via the NIK/IKK signaling complex. Oncogene 18:6013.
40. Natarajan, C., and J. J. Bright. 2002. Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J. Immunol. 169:6506.
41. Eberhardt, W., D. Kunz, R. Hummel, and J. Pfeilschifter. 1996. Molecular cloning of the rat inducible nitric oxides synthase gene promoter. Biochem. Biophys. Res. Commun. 223:752.
42. Lukiw, W., R. P. Pelaez, J. Martinez, and N. G. Bazan. 1998. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1β-induced. DNA binding activity of cis-acting transcription factors and epidermal keratinocytes. Proc. Natl. Acad. Sci. USA 95:3914.
43. Vogel, W., R. Lammers, J. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science 259:1611.
44. Lim, G. P., T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21:8370.
45. Li, W. Q., F. Dehnade, and M. Zafarullah. 2001. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J. Immunol. 166:3491.
46. Symes, A., N. Stahl, S. A. Reeves, T. Farruggella, T. Servidei, T. Gearan, G. Yancopoulos, and J. S. Fink. 1997. The protein tyrosine phosphatase SHP-2 negatively regulates cilliary neurotrophic factor induction of gene expression. Curr. Biol. 7:697.
47. Yu, C.-L., Y.-J. Jin, and S. J. Burakoff. 2000. Cytosolic tyrosine dephosphorylation of STAT5. J. Biol. Chem. 275:599
48. Ali, S., Z. Chen, J. J. Lebrun, W. Vogel, A. Kharitonenkov, P. A. Kelly, and A. Ullrich. 1996. PTPID is a positive regulator of the prolactin signal leading to β-casein promoter activation. EMBO J. 15:135.
49. David, M., G. Zhou, R. Pine, J. E. Dixon, and A. C. Larner. 1996. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon α/β-induced gene expression. J. Biol. Chem. 271:15862.
50. Marrero, M., V. J. Venema, H. Ju, D. C. Eaton, and R. Venema. 1998. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am. J. Physiol. 275:C1216.
51. Goebel, J., K. Forrest, L. Morford, and T. L. Roszman. 2002. Differential localization of IL-2 and -15 receptor chains in membrane rafts of human T cells. J. Leukocyte Biol. 72:199.
52. Lacalle, R. A., E. Mira, C. Gomez-Mouton, S. Jimenez-Baranda, C. Martinez-A, and S. Manes. 2002. Specific SHP-2 partitioning in raft domains triggers integrin-mediated signaling via Rho activation. J. Cell Biol. 157:277.
53. Sehgal, P. B., G. G. Guo, M. Shal, V. Kumar, and P. Kirit. 2002. Cytokine signaling. J. Biol. Chem. 277:12067.
54. Su, M. W.-C., C.-L. Yu, S. J. Burakoff, and Y.-J. Jin. 2001. Targefing Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation. J. Immunol. 166:3975.